Moffitt McKinley Outpatient Center

Tampa, Florida 33612

0 studies enrolling now · 3 studies all time

What they study most

Advanced Cutaneous Squamous Cell Carcinoma, Advanced Melanoma, Cutaneous Squamous Cell Carcinoma, Metastatic Cutaneous Squamous Cell Carcinoma, Solid Tumors Harboring a BRAF V600 Mutation

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran (RO7198457) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Participants With Previously Untreated Advanced Melanoma. — Completed
• Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer — Running, not enrolling
• A Phase Ib/II Study of LGX818 in Combination With MEK162 in Adult Patients With BRAF Dependent Advanced Solid Tumors — Completed